vs
CervoMed Inc.（CRVO）与Rigetti Computing, Inc.（RGTI）财务数据对比。点击上方公司名可切换其他公司
Rigetti Computing, Inc.的季度营收约是CervoMed Inc.的1.1倍（$1.9M vs $1.8M），CervoMed Inc.净利率更高（-356.1% vs -974.7%，领先618.6%），Rigetti Computing, Inc.同比增速更快（-17.9% vs -46.6%），过去两年CervoMed Inc.的营收复合增速更高（7.3% vs -21.8%）
CervoMed Inc.是一家处于临床阶段的生物制药公司，专注于开发阿尔茨海默病及其他类型痴呆等神经退行性疾病的新型疗法，业务覆盖全球生物制药市场，核心研发板块致力于满足进行性脑部疾病患者未被满足的医疗需求。
Rigetti Computing总部位于美国加利福尼亚州伯克利，是专业的超导量子集成电路研发商，产品主要应用于量子计算机领域。公司还推出了名为Forest的云平台，支持开发者编写各类量子算法。
CRVO vs RGTI — 直观对比
营收规模更大
RGTI
是对方的1.1倍
$1.8M
营收增速更快
RGTI
高出28.7%
-46.6%
净利率更高
CRVO
高出618.6%
-974.7%
两年增速更快
CRVO
近两年复合增速
-21.8%
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.8M | $1.9M |
| 净利润 | $-6.3M | $-18.2M |
| 毛利率 | — | 34.9% |
| 营业利润率 | -376.4% | -1209.7% |
| 净利率 | -356.1% | -974.7% |
| 营收同比 | -46.6% | -17.9% |
| 净利润同比 | -170.1% | 88.1% |
| 每股收益（稀释后） | — | $-0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRVORGTI
| Q4 25 | — | $1.9M | ||
| Q3 25 | — | $1.9M | ||
| Q2 25 | $1.8M | $1.8M | ||
| Q1 25 | $1.9M | $1.5M | ||
| Q4 24 | $2.2M | $2.3M | ||
| Q3 24 | $1.9M | $2.4M | ||
| Q2 24 | $3.3M | $3.1M | ||
| Q1 24 | $2.3M | $3.1M |
净利润CRVORGTI
| Q4 25 | — | $-18.2M | ||
| Q3 25 | — | $-201.0M | ||
| Q2 25 | $-6.3M | $-39.7M | ||
| Q1 25 | $-4.9M | $42.6M | ||
| Q4 24 | $-6.7M | $-153.0M | ||
| Q3 24 | $-4.8M | $-14.8M | ||
| Q2 24 | $-2.3M | $-12.4M | ||
| Q1 24 | $-2.5M | $-20.8M |
毛利率CRVORGTI
| Q4 25 | — | 34.9% | ||
| Q3 25 | — | 20.7% | ||
| Q2 25 | — | 31.4% | ||
| Q1 25 | — | 30.0% | ||
| Q4 24 | — | 44.1% | ||
| Q3 24 | — | 50.6% | ||
| Q2 24 | — | 64.5% | ||
| Q1 24 | — | 49.1% |
营业利润率CRVORGTI
| Q4 25 | — | -1209.7% | ||
| Q3 25 | — | -1055.4% | ||
| Q2 25 | -376.4% | -1103.9% | ||
| Q1 25 | -276.6% | -1469.6% | ||
| Q4 24 | -334.9% | -813.3% | ||
| Q3 24 | -278.2% | -729.4% | ||
| Q2 24 | -91.1% | -521.2% | ||
| Q1 24 | -110.6% | -543.4% |
净利率CRVORGTI
| Q4 25 | — | -974.7% | ||
| Q3 25 | — | -10321.9% | ||
| Q2 25 | -356.1% | -2201.8% | ||
| Q1 25 | -255.2% | 2895.3% | ||
| Q4 24 | -310.2% | -6726.5% | ||
| Q3 24 | -245.1% | -623.8% | ||
| Q2 24 | -70.4% | -402.5% | ||
| Q1 24 | -107.1% | -680.6% |
每股收益（稀释后）CRVORGTI
| Q4 25 | — | $-0.08 | ||
| Q3 25 | — | $-0.62 | ||
| Q2 25 | — | $-0.13 | ||
| Q1 25 | — | $0.13 | ||
| Q4 24 | — | $-0.80 | ||
| Q3 24 | $-0.55 | $-0.08 | ||
| Q2 24 | — | $-0.07 | ||
| Q1 24 | — | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $33.5M | $44.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $33.4M | $546.2M |
| 总资产 | $38.1M | $666.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CRVORGTI
| Q4 25 | — | $44.9M | ||
| Q3 25 | — | $26.1M | ||
| Q2 25 | $33.5M | $57.2M | ||
| Q1 25 | $35.2M | $37.2M | ||
| Q4 24 | $38.9M | $67.7M | ||
| Q3 24 | $46.7M | $20.3M | ||
| Q2 24 | $45.1M | $20.7M | ||
| Q1 24 | $6.4M | $35.1M |
股东权益CRVORGTI
| Q4 25 | — | $546.2M | ||
| Q3 25 | — | $371.8M | ||
| Q2 25 | $33.4M | $553.3M | ||
| Q1 25 | $34.6M | $207.1M | ||
| Q4 24 | $39.2M | $126.6M | ||
| Q3 24 | $45.6M | $122.8M | ||
| Q2 24 | $50.0M | $122.2M | ||
| Q1 24 | $5.3M | $115.6M |
总资产CRVORGTI
| Q4 25 | — | $666.6M | ||
| Q3 25 | — | $630.3M | ||
| Q2 25 | $38.1M | $636.7M | ||
| Q1 25 | $38.6M | $269.1M | ||
| Q4 24 | $43.1M | $284.8M | ||
| Q3 24 | $48.9M | $157.3M | ||
| Q2 24 | $53.2M | $162.4M | ||
| Q1 24 | $8.0M | $162.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.5M | $-14.9M |
| 自由现金流经营现金流 - 资本支出 | — | $-19.5M |
| 自由现金流率自由现金流/营收 | — | -1042.5% |
| 资本支出强度资本支出/营收 | — | 244.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-77.2M |
8季度趋势，按日历期对齐
经营现金流CRVORGTI
| Q4 25 | — | $-14.9M | ||
| Q3 25 | — | $-13.8M | ||
| Q2 25 | $-6.5M | $-16.2M | ||
| Q1 25 | $-3.9M | $-13.7M | ||
| Q4 24 | $-8.1M | $-8.5M | ||
| Q3 24 | $-4.9M | $-15.4M | ||
| Q2 24 | $-2.2M | $-13.5M | ||
| Q1 24 | $-1.4M | $-13.1M |
自由现金流CRVORGTI
| Q4 25 | — | $-19.5M | ||
| Q3 25 | — | $-19.7M | ||
| Q2 25 | — | $-21.8M | ||
| Q1 25 | — | $-16.2M | ||
| Q4 24 | — | $-9.8M | ||
| Q3 24 | — | $-17.7M | ||
| Q2 24 | — | $-15.6M | ||
| Q1 24 | — | $-18.6M |
自由现金流率CRVORGTI
| Q4 25 | — | -1042.5% | ||
| Q3 25 | — | -1012.4% | ||
| Q2 25 | — | -1212.4% | ||
| Q1 25 | — | -1100.4% | ||
| Q4 24 | — | -432.1% | ||
| Q3 24 | — | -744.5% | ||
| Q2 24 | — | -504.3% | ||
| Q1 24 | — | -610.5% |
资本支出强度CRVORGTI
| Q4 25 | — | 244.8% | ||
| Q3 25 | — | 302.5% | ||
| Q2 25 | — | 314.7% | ||
| Q1 25 | — | 173.0% | ||
| Q4 24 | — | 56.4% | ||
| Q3 24 | — | 95.8% | ||
| Q2 24 | — | 66.3% | ||
| Q1 24 | — | 180.0% |
现金转化率CRVORGTI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.32× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRVO
暂无分部数据
RGTI
| Collaborative Research And Other Professional Services | $1.7M | 93% |
| Other | $131.0K | 7% |
